Daylight Saving Time Ending: Potential Health Effects
The good news: You will get a glorious extra hour of sleep. The bad: It’ll be dark as a pocket by late afternoon for the next few months in …
‘I Got Fit Over 40 And Built Muscle With These Changes’
After reaching my heaviest weight ever in 2016, I had an awakening of sorts. I had hit my nine-month pregnancy weight, but I was not pregnant. I am an …
MMRI professor receives $3.7 million NIH grant to support research on pulmonary embolism
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) recently awarded a $3.7 million grant to support a project led by Principal Investigator, …
What It Is And How To Use It, Per Experts
How hungry are you right now on a scale of zero to ten? If you’re not super-hungry or super-full, it might be hard to answer. The hunger-fullness scale can …
Wayne State University researcher secures $2.3 million for Alzheimer’s studies
A Wayne State University School of Medicine faculty member has been awarded a total of $2.3 million by the National Institute on Aging of the National institutes of Health …
Inside Taylor Swift and Travis Kelce’s Relationship at Six Months
Taylor Swift and Travis Kelce are “closer than ever before,” a source told Entertainment Tonight. “They try to lead as normal lives as possible as a couple,” the source …
Global analysis reveals tripling of chronic kidney disease cases in women
A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three decades. Also, type 2 diabetes …
GLP-1RA not associated with acute kidney injury risk during anti-cancer treatments
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, …
New analysis confirms canagliflozin’s cardiovascular and kidney benefits in older adults
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on …
New trial shows felzartamab reduces proteinuria in IgA nephropathy patients
IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2 trial revealed that felzartamab, …